"Dr Reddy"

Latest news and video coverage curated from trusted media outlets


0 shares	Share Tweet Save Post Send


Monoclonal antibodies control Covid symptoms in 24 hours, says AIG chairman Dr Reddy \| Oneindia News Around 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad-based Asian Institute of Gastroenterology. Chairperson of the hospital, Dr Nageshwar Reddy said.. Credit: Oneindia Duration: 01:40Published 16 hours ago

Covid-19: 75 patients died at Goa's biggest hospital in past four days\| Oneindia News Seventy-five patients have died at the Goa Medical College and Hospital the state's biggest Covid facility in the past four days. With disturbing reports of mishandling of Covid-19 bodies emerging.. Credit: Oneindia Duration: 03:01Published on May 14, 2021


42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials Institute of Nuclear Medicine and Allied Sciences-DRDO scientist Dr Sudhir Chandna on drug 2-deoxy-D-glucose (2-DG) while speaking to ANI informed about the observations of the medicine's clinical.. Credit: ANI Duration: 01:59Published on May 9, 2021

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen From DCGI approving new anti-Covid drug, to health ministry issues new rules for hospital admissions, here are the top updates on the coronavirus. DCGI approved a new anti-Covid oral drug, which has.. Credit: HT Digital Content Duration: 03:24Published on May 8, 2021

Sensex up 424 points as RBI unveils COVID relief measures Key equity indices traded in the green on Wednesday as RBI Governor Shaktikanta Das launched the second round of loan restructuring and other relief measures to counter the impact of Covid-19's second.. Credit: ANI Duration: 01:12Published on May 5, 2021

Sputnik V is stored at -18C: Dr Reddy's Lab Global Logistics' Head Sputnik V is a minus 18-degrees Celsius storage vaccine, informed Ravi Mathur, Global Logistics' Head, Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01."Sputnik V is a.. Credit: ANI Duration: 01:43Published on May 1, 2021

Sputnik V will be available in few weeks after statutory clearances: Dr Reddy's Lab CEO The Sputnik V vaccine will be available in a few weeks after statutory clearances, informed Deepak Sapra, CEO of Dr Reddy's Laboratories after the Russian vaccines arrived in India on May 01. "Today,.. Credit: ANI Duration: 01:02Published on May 1, 2021

150,000 doses of Sputnik V have arrived in India on 1st May \| Oneindia News Sputnik V is the Russian made covid vaccine with an efficacy rate above 90%. 150,000 doses of Sputnik have arrived at Hyderabad in India on Saturday. The vaccines will be handed over to Dr Reddy's.. Credit: Oneindia Duration: 01:01Published on May 1, 2021

Equity indices trade flat, Infosys drops 3.8 pc Equity benchmark indices traded flat during early hours on April 15 amid an interplay of resurgence in COVID-19 cases and the pace of vaccination. Investors tracked updates on the vaccines approval and.. Credit: ANI Duration: 01:17Published on April 15, 2021

You Might Like

Russian made Sputnik V to be available at Delhi`s hospital from next week, check details The first phase of the Sputnik V rollout by Apollo Hospitals and Dr Reddy`s Laboratories had started on a pilot basis on May 17 in Hyderabad and on May 18 in Vishakhapatnam. Zee News - Published 9 hours ago
Shrikant Chouhan: BUY SBI and Dr Reddy’s TopNews - Published 3 days ago
Hyderabad's Rockwell collaborates with Dr Reddy's lab to provide vaccine freezers for Sputnik V rollout newKerala.com - Published 4 days ago

Covid-19 vaccine tender: All bids junked by BMC All nine potential suppliers disqualified due to lack of documentation; BMC turns to Dr. Reddy’s for experimental supply of Sputnik Mid-Day - Published 1 week ago
Snowman Logistics partners with Dr. Reddy's for Sputnik vax in India newKerala.com - Published 1 week ago
COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in India Pune-based Serum Institute has also sought approval for test analysis and examination. Sputnik V is currently being manufactured by Dr Reddy's Lab. DNA - Published 2 weeks ago

Sudarshan Sukhani: BUY HDFC, Dr Reddy’s, JSW Steel; SELL InfoEdge India TopNews - Published 2 weeks ago
COVID-19 vaccine: 'Sputnik V' to be available in Delhi after June 20, says Kejriwal The Delhi Government has been in talks with Dr Reddy's Laboratories for the supply of the 'Sputnik V' vaccine. DNA - Published 2 weeks ago
No tie-up with any firm for supplying Sputnik V vaccine: Dr. Reddy's Laboratories, RDIF newKerala.com - Published 2 weeks ago
Dr Reddy’s warns against fake Sputnik V suppliers Amid reports coming in from various states about multiple Sputnik V suppliers responding to their global vaccine tenders, Dr Reddy's Labs said it is the sole custodian of the Russian vaccine in India... IndiaTimes - Published 2 weeks ago

No partnership with any firm to supply Sputnik V: RDIF, Dr Reddy’s Indian Express - Published 2 weeks ago
Not authorised any 3rd party to supply Sputnik V in India, legal action against unscrupulous elements: Dr Reddy’s & RDIF IndiaTimes - Published 2 weeks ago
Dr Reddy’s fixes price of DRDO’s 2-DG anti-COVID drug at Rs 990 per sachet DRDO's anti-COVID-19 drug 2-DG will be supplied to government hospitals, the central and state governments at a discounted price. Zee News - Published 2 weeks ago	If approved, Sputnik Light could become first single-dose vaccine to be launched in India The two-dose Sputnik V had received the Indian drug regulator's permission for restricted emergency use with certain conditions on April 12. Dr Reddy's Laboratories is importing the vaccine for use in.. Zee News - Published 2 weeks ago
Sputnik V’s cold-storage needs may delay availability in region: Hospitals The Russian-made Sputnik V vaccine may take a while to land in Pune. Private hospitals in the city that are mulling procurement said they are yet to receive a response to enquiries from Hyderabad-based.. IndiaTimes - Published 3 weeks ago	Mumbai: Agripada residents buy Sputnik for vaccination drive at nearby hospital The Mumbai Central and Agripada Advanced Locality Management (MCA ALM) will next week roll out the city’s first citizen-driven cluster vaccination for residents of their area. The ALM has tied up.. IndiaTimes - Published 3 weeks ago
Sudarshan Sukhani: BUY Tech Mahindra, UPL, Zee and Dr Reddy’s TopNews - Published 3 weeks ago	Dr Reddy’s developing new treatment options for COVID-19, says MD Indian Express - Published 3 weeks agoAlso reported by •IndiaTimes
Prices of Sputnik V COVID-19 vaccine may drop after local manufacturing begins: Dr Reddy's newKerala.com - Published 3 weeks ago	DRDO’s anti-COVID-19 drug 2-DG likely to be available by mid-June: Dr Reddy`s In a statement, Hyderabad based Dr Reddy's clarified that 2-DG is not yet available in the market and the commercial launch of the drug is expected by mid-June. Zee News - Published on May 20, 2021Also reported by •IndiaTimes
Dr Reddy's in talks with RDIF on Sputnik V for other countries Dr Reddy's Laboratories, which is in a pact with Russian Direct Investment Fund to sell 125 million people doses (250 million vials) of Covid-19 vaccine Sputnik V in India, is holding parleys with RDIF.. IndiaTimes - Published on May 19, 2021	Sputnik V debuts on Co-Win at Rs 1,250 a dose as Dr Reddy’s ties with Apollo Russian Covid-19 vaccine Sputnik V made its debut on the Co-Win Covid-19 vaccination platform with Dr Reddy’s Laboratories announcing a national tie-up with Apollo Hospitals for Russian Covid-19.. IndiaTimes - Published on May 18, 2021
DRDO's anti-COVID 2-DG drug an add-on, not substitute for other medicines: Dr Reddy's CEO newKerala.com - Published on May 17, 2021	Dr Reddy's labs, Apollo hospitals launch pilot programme for administering Russian COVID vaccine Sputnik V newKerala.com - Published on May 17, 2021
Apollo Hospitals, Dr Reddy's announce Covid-19 vaccination programme with Sputnik V Apollo Hospitals and Dr Reddy's Laboratories on Monday said they are collaborating to initiate a Covid-19 vaccination programme with Sputnik V. The first phase of the programme will kick off with.. IndiaTimes - Published on May 17, 2021	This co inks pact with Dr Reddy's to mfg Sputnik V vaccine Drug firm Shilpa Medicare on Monday said its arm has entered into a definitive agreement with Dr Reddy's Laboratories for manufacturing of Russian Covid-19 vaccine Sputnik V. IndiaTimes - Published on May 17, 2021
Rajnath Singh to release first batch of DRDO's anti-COVID oral drug 2DG today Developed by DRDO's INMAS, in collaboration with Dr Reddy's Laboratories in Hyderabad, the 2DG drug is an anti-Covid therapeutic application. DNA - Published on May 17, 2021	Dr Reddy's posts Q4 profit of Rs 554 crore, revenues at Rs 4,728 crore newKerala.com - Published on May 14, 2021
Dr Reddy's announces launch of Sputnik vaccine in Indian market newKerala.com - Published on May 14, 2021	Dr Reddy's to get 36m doses of Sputnik V vaccine in next few months Indian drug maker Dr. Reddy's Laboratories Ltd said on Friday it expects to get 36 million doses of Sputnik V Covid-19 vaccine in the next couple of months under its contract with Russia's sovereign.. IndiaTimes - Published on May 14, 2021
Russia’s Sputnik V COVID-19 vaccine to be available in India soon, know price and other details Russia's Sputnik V vaccine will be available in India in collaboration with Dr. Reddy’s Lab. A dose of imported Sputnik 5V vaccine in India will be priced at Rs 995 including 5 percent GST. Zee News - Published on May 14, 2021	Russian COVID-19 vaccine Sputnik V to cost Rs 995.40 per dose, reveals Dr Reddy`s Laboratories Dr Reddy's Laboratories on Friday (May 14, 2021) announced that Russian COVID-19 vaccine Sputnik V will cost ₹995.40 + 5% GST per dose in India and the price of vaccines produced in the country may.. Zee News - Published on May 14, 2021
Dr Reddy's rolls out Sputnik V Covid-19 vaccine in India at around Rs 995 per dose Dr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose being administered in Hyderabad on Friday.. IndiaTimes - Published on May 14, 2021	As India eyes Sputnik rollout, experts question efficacy data Even as India is gearing up to roll out Russian Covid-19 vaccine Sputnik V next week, a group of international experts has raised serious questions about the data discrepancies and substandard.. IndiaTimes - Published on May 13, 2021
Dr Reddy's to manufacture baricitinib for Covid treatment newKerala.com - Published on May 12, 2021	2-deoxy-D-glucose: DRDO`s anti-COVID-19 drug is safe, will help patients recover faster, says INMAS scientist Anti-COVID-19 drug 2-deoxy-D-glucose (2-DG) has been developed by INMAS, a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy`s Laboratories (DRL), Hyderabad. Zee News - Published on May 12, 2021
Dr Reddy's inks licensing pact with Eli Lilly for Covid-19 treatment drug Dr Reddy's Laboratories on Tuesday said it has inked a licensing pact with Eli Lilly and Company to produce Baricitinib in the country for treatment of Covid-19. IndiaTimes - Published on May 11, 2021	Mumbai: Sensex jumps 296 points, pharma stocks surge Among stocks, Coal India moved up by 8 per cent to Rs 148.10 per share. Pharma majors Dr Reddy`s and Sun Pharma were up by 3 per cent and 2.7 per cent respectively. Mid-Day - Published on May 10, 2021
Equities on upswing, Dr Reddy's gains 3.3 pc newKerala.com - Published on May 10, 2021	Sensex surges over 350 points in early trade; Nifty tops 14,900 Dr Reddy`s was the top gainer in the Sensex pack, rising over 2 per cent, followed by ONGC, HDFC, IndusInd Bank, ICICI Bank, Sun Pharma and Kotak Bank. Mid-Day - Published on May 10, 2021
Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency use A potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) – has received the Drugs Controller General of India (DCGI) nod for emergency use as adjunct therapy for.. IndiaTimes - Published on May 8, 2021	DCGI gives nod to anti-COVID drug developed by DRDO for emergency use The Drugs Controller General of India (DCGI) on Saturday (May 8, 2021) approved drug 2-deoxy-D-glucose (2-DG) which is developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO in.. Zee News - Published on May 8, 2021
Sensex ends 465 points lower, Nifty slips below 14,500 amid lockdown and IPL suspension The 30-share BSE index ended 465.01 points or 0.95 percent lower at 48,253.51, and the broader NSE Nifty slumped 137.65 points or 0.94 percent to 14,496.50. Dr Reddy's was the top loser in the Sensex.. Zee News - Published on May 4, 2021	Russia`s COVID-19 vaccine Sputnik V arrives in Hyderabad Last month, the Drug Controller General (DCGI) had issued permission for Dr. Reddy's Laboratories to import the Russian vaccine to India for emergency use. The rollout of the Russian vaccine is.. Zee News - Published on May 1, 2021
Sensex slumps 984 points, Nifty ends below 14,650; financial stocks lead sell off HDFC twins were the top losers in the Sensex pack, shedding over 4 percent, followed by ICICI Bank, Kotak Bank, Asian Paints, M&M, HUL, TCS, and Maruti. On the other hand, ONGC, Sun Pharma, Dr. Reddy,.. Zee News - Published on April 30, 2021	Mitesh Thakkar: BUY ICICI Lombard, Axis Bank, Dr Reddy’s; SELL HCL Technologies TopNews - Published on April 27, 2021

"Dr Reddy"

Latest news and video coverage curated from trusted media outlets

You Might Like

Russian made Sputnik V to be available at Delhi`s hospital from next week, check details

Shrikant Chouhan: BUY SBI and Dr Reddy’s

Hyderabad's Rockwell collaborates with Dr Reddy's lab to provide vaccine freezers for Sputnik V rollout

Covid-19 vaccine tender: All bids junked by BMC

Snowman Logistics partners with Dr. Reddy's for Sputnik vax in India

COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in India

Sudarshan Sukhani: BUY HDFC, Dr Reddy’s, JSW Steel; SELL InfoEdge India

COVID-19 vaccine: 'Sputnik V' to be available in Delhi after June 20, says Kejriwal

No tie-up with any firm for supplying Sputnik V vaccine: Dr. Reddy's Laboratories, RDIF

Dr Reddy’s warns against fake Sputnik V suppliers

No partnership with any firm to supply Sputnik V: RDIF, Dr Reddy’s

Not authorised any 3rd party to supply Sputnik V in India, legal action against unscrupulous elements: Dr Reddy’s & RDIF

Dr Reddy’s fixes price of DRDO’s 2-DG anti-COVID drug at Rs 990 per sachet

If approved, Sputnik Light could become first single-dose vaccine to be launched in India

Sputnik V’s cold-storage needs may delay availability in region: Hospitals

Mumbai: Agripada residents buy Sputnik for vaccination drive at nearby hospital

Sudarshan Sukhani: BUY Tech Mahindra, UPL, Zee and Dr Reddy’s

Dr Reddy’s developing new treatment options for COVID-19, says MD

Prices of Sputnik V COVID-19 vaccine may drop after local manufacturing begins: Dr Reddy's

DRDO’s anti-COVID-19 drug 2-DG likely to be available by mid-June: Dr Reddy`s

Dr Reddy's in talks with RDIF on Sputnik V for other countries

Sputnik V debuts on Co-Win at Rs 1,250 a dose as Dr Reddy’s ties with Apollo

DRDO's anti-COVID 2-DG drug an add-on, not substitute for other medicines: Dr Reddy's CEO

Dr Reddy's labs, Apollo hospitals launch pilot programme for administering Russian COVID vaccine Sputnik V

Apollo Hospitals, Dr Reddy's announce Covid-19 vaccination programme with Sputnik V

This co inks pact with Dr Reddy's to mfg Sputnik V vaccine

Rajnath Singh to release first batch of DRDO's anti-COVID oral drug 2DG today

Dr Reddy's posts Q4 profit of Rs 554 crore, revenues at Rs 4,728 crore

Dr Reddy's announces launch of Sputnik vaccine in Indian market

Dr Reddy's to get 36m doses of Sputnik V vaccine in next few months

Russia’s Sputnik V COVID-19 vaccine to be available in India soon, know price and other details

Russian COVID-19 vaccine Sputnik V to cost Rs 995.40 per dose, reveals Dr Reddy`s Laboratories

Dr Reddy's rolls out Sputnik V Covid-19 vaccine in India at around Rs 995 per dose

As India eyes Sputnik rollout, experts question efficacy data

Dr Reddy's to manufacture baricitinib for Covid treatment

2-deoxy-D-glucose: DRDO`s anti-COVID-19 drug is safe, will help patients recover faster, says INMAS scientist

Dr Reddy's inks licensing pact with Eli Lilly for Covid-19 treatment drug

Mumbai: Sensex jumps 296 points, pharma stocks surge

Equities on upswing, Dr Reddy's gains 3.3 pc

Sensex surges over 350 points in early trade; Nifty tops 14,900

Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency use

DCGI gives nod to anti-COVID drug developed by DRDO for emergency use

Sensex ends 465 points lower, Nifty slips below 14,500 amid lockdown and IPL suspension

Russia`s COVID-19 vaccine Sputnik V arrives in Hyderabad

Sensex slumps 984 points, Nifty ends below 14,650; financial stocks lead sell off

Mitesh Thakkar: BUY ICICI Lombard, Axis Bank, Dr Reddy’s; SELL HCL Technologies